Understanding ZC3H11A: Potential Drug Target Or Biomarker (G9877)

Target Name: ZC3H11A

NCBI ID: G9877

ZC3H11A

Understanding ZC3H11A: Potential Drug Target Or Biomarker

ZC3H11A, also known as ZC11A or HUMAN Zinc Transporter 11, is a protein that is expressed in a wide range of tissues throughout the body. It is a member of the Zinc Transporter family, which is a subfamily of the Transient Activator of Transcription (TAT) family. ZC3H11A is primarily expressed in the brain, heart, and pancreas, and has been shown to play a role in a number of physiological processes, including cell signaling, neurotransmitter transport, and inflammation.

One of the most promising aspects of ZC3H11A is its potential as a drug target. The use of small molecules, such as drugs, to inhibit or activate specific genes is a common method of treating genetic disorders. By blocking or activating ZC3H11A, researchers can gain insights into its function and develop new treatments for a variety of diseases.

One of the key challenges in studying ZC3H11A is its high degree of gene expression. ZC3H11A is expressed in virtually all tissues of the body, which makes it difficult to study its function in specific organs or cells. However, researchers have been able to use RNA interference (RNAi) technology to knockdown the expression of ZC3H11A in certain tissues and cells, allowing them to study its effects in greater detail.

In addition to its potential as a drug target, ZC3H11A has also been shown to be a valuable biomarker for a number of diseases. For example, ZC3H11A has been used to diagnose and monitor pancreatic cancer, using a technique called targeted sequencing. This approach allows researchers to identify specific genes that are expressed in pancreatic cancer cells, which can then be used to develop new treatments for the disease.

ZC3H11A has also been used to study a variety of other diseases, including neurodegenerative disorders, autoimmune diseases, and psychiatric conditions. For example, studies have shown that ZC3H11A is expressed in the brains of individuals with Alzheimer's disease, and that inhibiting its function may be a potential treatment for the disease.

In addition to its potential as a drug target and biomarker, ZC3H11A is also of interest to researchers because of its unique structure and biology. ZC3H11A is a member of the Zinc Transporter family, which is characterized by a specific transmembrane protein that allows zinc ions to enter the cell. This structure allows ZC3H11A to interact with other proteins that are involved in zinc signaling, providing a potential avenue for study.

Overall, ZC3H11A is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its high degree of gene expression and unique biology make it an attractive subject for research, and its potential as a diagnostic tool for pancreatic cancer adds to its relevance. Further studies are needed to fully understand the function of ZC3H11A and its potential as a drug.

Protein Name: Zinc Finger CCCH-type Containing 11A

Functions: RNA-binding protein that interacts with purine-rich sequences and is involved in nuclear mRNA export; probably mediated by association with the TREX complex

The "ZC3H11A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZC3H11A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets